Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| APO-LEVETIRACETAM | APOTEX INC | Actual shortage | 750MG | Updated Report | 2021-01-20 | 131875 |
| APO-ATOMOXETINE | APOTEX INC | Actual shortage | 10MG | Updated Report | 2021-01-20 | 131812 |
| APO-ALENDRONATE/VITAMIN D3 | APOTEX INC | Actual shortage | 70MG 5600UNIT | Updated Report | 2021-01-20 | 128922 |
| APO-RAMIPRIL | APOTEX INC | Resolved | 5MG | Updated Report | 2021-01-20 | 131176 |
| APO-FLECAINIDE | APOTEX INC | Resolved | 50MG | Updated Report | 2021-01-20 | 131160 |
| APO-ALFUZOSIN | APOTEX INC | Resolved | 10MG | Updated Report | 2021-01-20 | 131809 |
| APO-DEFERASIROX (TYPE J) | APOTEX INC | Resolved | 360MG | Updated Report | 2021-01-20 | 130040 |
| APO-DEFERASIROX (TYPE J) | APOTEX INC | Resolved | 90MG | Updated Report | 2021-01-20 | 131151 |
| APO-DEFERASIROX (TYPE J) | APOTEX INC | Resolved | 180MG | Updated Report | 2021-01-20 | 131148 |
| XYLOCAINE 2% W EPINEPHRINE 1:200000 | ASPEN PHARMACARE CANADA INC. | Actual shortage | 20MG 5MCG | Updated Report | 2021-01-20 | 131563 |
| XYLOCAINE 2% | ASPEN PHARMACARE CANADA INC. | Anticipated shortage | 20MG | New Report | 2021-01-20 | 132070 |
| PHENYTOIN SODIUM INJECTION, USP | STERIMAX INC | Resolved | 50MG | Updated Report | 2021-01-20 | 130361 |
| INDAYO | MYLAN PHARMACEUTICALS ULC | Actual shortage | 0.15MG 0.03MG | Updated Report | 2021-01-20 | 130872 |
| SYNTHROID | BGP PHARMA ULC | Actual shortage | 150MCG | Updated Report | 2021-01-20 | 131538 |
| SYNTHROID | BGP PHARMA ULC | Actual shortage | 137MCG | Updated Report | 2021-01-20 | 131541 |
| SYNTHROID | BGP PHARMA ULC | Avoided shortage | 75MCG | Updated Report | 2021-01-20 | 131535 |
| SYNTHROID | BGP PHARMA ULC | Actual shortage | 50MCG | Updated Report | 2021-01-20 | 129829 |
| SYNTHROID | BGP PHARMA ULC | Anticipated shortage | 125MCG | Updated Report | 2021-01-20 | 130583 |
| SYNTHROID | BGP PHARMA ULC | Anticipated shortage | 112MCG | Updated Report | 2021-01-20 | 130840 |
| SERC | BGP PHARMA ULC | Actual shortage | 16MG | Updated Report | 2021-01-20 | 128455 |
| LIPIDIL EZ | BGP PHARMA ULC | Actual shortage | 145MG | Updated Report | 2021-01-20 | 125754 |
| KADIAN | BGP PHARMA ULC | Actual shortage | 10MG | Updated Report | 2021-01-20 | 129190 |
| LUVOX | BGP PHARMA ULC | Anticipated shortage | 100MG | Updated Report | 2021-01-20 | 130580 |
| LUVOX | BGP PHARMA ULC | Anticipated shortage | 50MG | Updated Report | 2021-01-20 | 131544 |
| MYLAN-LAMOTRIGINE | MYLAN PHARMACEUTICALS ULC | Avoided shortage | 100MG | Updated Report | 2021-01-20 | 130878 |
| MYLAN-VERAPAMIL SR | MYLAN PHARMACEUTICALS ULC | Anticipated shortage | 180MG | Updated Report | 2021-01-20 | 120686 |
| MYLAN-BUPROPION XL | MYLAN PHARMACEUTICALS ULC | Actual shortage | 150MG | Updated Report | 2021-01-20 | 125767 |
| MYLAN-PROPAFENONE | MYLAN PHARMACEUTICALS ULC | Actual shortage | 150MG | Updated Report | 2021-01-20 | 129179 |
| MYLAN-GLICLAZIDE MR | MYLAN PHARMACEUTICALS ULC | Anticipated shortage | 30MG | New Report | 2021-01-20 | 132033 |
| CONTINGENCY ONE | MYLAN PHARMACEUTICALS ULC | Actual shortage | 1.5MG | Updated Report | 2021-01-20 | 130854 |
| MYLAN-CILAZAPRIL | MYLAN PHARMACEUTICALS ULC | Actual shortage | 5.0MG | Updated Report | 2021-01-20 | 130875 |
| MYLAN-RILUZOLE | MYLAN PHARMACEUTICALS ULC | Anticipated shortage | 50MG | New Report | 2021-01-20 | 132026 |
| ELETRIPTAN | PRO DOC LIMITEE | Actual shortage | 20MG | Updated Report | 2021-01-20 | 125196 |
| VOLTAREN OPHTHA | NOVARTIS PHARMACEUTICALS CANADA INC | Resolved | 0.1% | Updated Report | 2021-01-20 | 130021 |
| SANDOZ ARIPIPRAZOLE | SANDOZ CANADA INCORPORATED | Resolved | 2MG | Updated Report | 2021-01-20 | 131382 |
| LOESTRIN 1.5/30 | ALLERGAN INC | Resolved | 1.5MG 30MCG | Updated Report | 2021-01-20 | 130389 |
| DILAUDID | PURDUE PHARMA | Actual shortage | 4MG | Updated Report | 2021-01-20 | 132013 |
| AURO-MIRTAZAPINE | AURO PHARMA INC | Actual shortage | 15MG | Updated Report | 2021-01-19 | 132016 |
| IOPIDINE | NOVARTIS PHARMACEUTICALS CANADA INC | Actual shortage | 1% | Updated Report | 2021-01-19 | 128186 |
| AURO-LISINOPRIL | AURO PHARMA INC | Actual shortage | 10MG | New Report | 2021-01-19 | 132007 |
| AURO-LACOSAMIDE | AURO PHARMA INC | Actual shortage | 100MG | New Report | 2021-01-19 | 132002 |
| AURO-LACOSAMIDE | AURO PHARMA INC | Actual shortage | 150MG | New Report | 2021-01-19 | 131291 |
| AURO-GALANTAMINE ER | AURO PHARMA INC | Actual shortage | 16MG | Updated Report | 2021-01-19 | 131996 |
| TAZORAC | ALLERGAN INC | Actual shortage | 0.1% | Updated Report | 2021-01-19 | 118029 |
| ACUVAIL | ALLERGAN INC | Anticipated shortage | 0.45% | New Report | 2021-01-19 | 131991 |
| ANDRODERM | ALLERGAN INC | Actual shortage | 2.5MG | New Report | 2021-01-19 | 131988 |
| AURO-GABAPENTIN | AURO PHARMA INC | Actual shortage | 100MG | Updated Report | 2021-01-19 | 131985 |
| AURO-ELETRIPTAN | AURO PHARMA INC | Actual shortage | 40MG | Updated Report | 2021-01-19 | 131257 |
| AURO-DUTASTERIDE | AURO PHARMA INC | Actual shortage | 0.5MG | Updated Report | 2021-01-19 | 131980 |
| AURO-CLINDAMYCIN | AURO PHARMA INC | Actual shortage | 150MG | Updated Report | 2021-01-19 | 128761 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| APO-CELECOXIB | APOTEX INC | Discontinued | 200MG | Updated Report | 2021-01-20 | 60366 |
| IMURAN | ASPEN PHARMACARE CANADA INC. | To be discontinued | 50MG | Updated Report | 2021-01-18 | 128667 |
| HUMATROPE | ELI LILLY CANADA INC | Discontinued | 1MG | Updated Report | 2021-01-18 | 106800 |
| LIVOSTIN SUS NAS 0.5MG/ML | JANSSEN INC | Discontinued | 0.05MG | Updated Report | 2021-01-13 | 117970 |
| ODAN-METHADONE | ODAN LABORATORIES LTD | Reversed | 10MG | New Report | 2020-12-31 | 126845 |
